Bacterial Spores Inspire Novel Cancer Drug Delivery System

January 24, 2023 by Dan McCue
Bacterial Spores Inspire Novel Cancer Drug Delivery System
Three-dimensional illustration of a SSHEL drug delivery system. An inner porous silica-based cavity carrying cargo (dark red) is coated by a membrane (yellow) and protein layers (purple, green), which serve as a platform to attach cancer-targeting molecules (pink protrusions).

WASHINGTON — Scientists with the National Cancer Institute’s Center for Cancer Research have come up with a new way to get life-saving drugs directly into cancer cells, an advance they say will enable more effective treatments for cancer with fewer side effects.

The research was originally published in Cell Reports.

As noted in a press release from the agency, the side effects of some chemotherapy drugs can range from nausea and fatigue to mood changes and nerve problems, as well as damage to healthy cells and organs.

“These side effects are a huge deterrent for people getting chemotherapy,” said Kumaran Ramamurthi, Ph.D., senior investigator and deputy chief of the Laboratory of Molecular Biology, in a written statement.

Ramamurthi, who was also lead investigator of the study, went on to say, “One way to solve this problem is to make sure that chemotherapy drugs reach only the cancer and not surrounding tissue.”

Ramamurthi’s team created artificial, bacterial spore-like particles that can target cancer while carrying chemotherapeutic cargo. 

The product, called a SSHEL (short for Synthetic Spore Husk-Encased Lipid bilayers), consists of a porous glass bead surrounded by a membrane and a protein coat dotted with cancer-targeting molecules. 

To test their concept, the team collaborated with the groups headed by David Fitzgerald, Ph.D., senior investigator in the Laboratory of Molecular Biology, and Kandice Tanner, Ph.D., senior investigator in the Laboratory of Cell Biology, to use a mouse model of HER2-positive ovarian cancer, which is sometimes treated with a chemotherapy drug called doxorubicin. 

They loaded doxorubicin into SSHELs designed to home in on HER2 proteins and then injected the SSHELs into the mice. Compared to the leading doxorubicin delivery method (doxorubicin encased in a fat-based sphere), the SSHELs shrank the tumors more effectively and with fewer side effects, the release said.

In a serendipitous twist, it was the cancer cell’s own machinery that secured its demise. The team’s initial goal was to reach the cancer and then work on drug release, but when the SSHELs contacted the cancer cell surface, they were trafficked into an acidic area of the cell. This destabilized the SSHEL particle and released the doxorubicin cargo. 

“That was unexpected, but it was fortuitous,” Ramamurthi said.

The team confirmed their findings in a transparent zebrafish model of ovarian cancer. Using fluorescent markers, they tracked the SSHELs at the surface of cancer cells and inside acidic compartments.

Ramamurthi and collaborators plan to examine the utility of SSHELs in another mouse model, but he emphasized in a written statement that the relevance of SSHEL extends far beyond ovarian cancer and chemotherapeutic drug delivery.

“We’re providing a versatile platform that could be used for a lot of different applications. Tell us what should be targeted, and we could provide a vehicle to get the cargo there,” he said.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

A+
a-
  • bacterial spores
  • cancer research
  • drug delivery
  • health
  • Research
  • science
  • In The News

    Health

    Voting

    Research

    December 6, 2023
    by Dan McCue
    New Report Sheds Some Light on Rare Post-COVID Shot Syndrome

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but... Read More

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but chronic and debilitating condition some people report experiencing after getting a COVID-19 vaccination. The paper, which was posted on the preprint server medRxiv and has not... Read More

    November 7, 2023
    by Jesse Zucker
    Getting Quality Sleep Impacts Health and Fitness

    WASHINGTON — We’ve all woken up feeling groggy and dreading the day ahead. When you’re busy and stressed, it’s hard... Read More

    WASHINGTON — We’ve all woken up feeling groggy and dreading the day ahead. When you’re busy and stressed, it’s hard to get to bed early. Even if you manage an early bedtime, sometimes you can’t fall asleep. The CDC states that 33% of adults sleep less... Read More

    Mind-Altering Ketamine Becomes Latest Pain Treatment, Despite Little Research

    WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking... Read More

    WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy. Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth... Read More

    AI Raises Fears About Risks to Humanity. Are Tech and Political Leaders Doing Enough?

    LONDON (AP) — Chatbots like ChatGPT wowed the world with their ability to write speeches, plan vacations or hold a conversation as good... Read More

    LONDON (AP) — Chatbots like ChatGPT wowed the world with their ability to write speeches, plan vacations or hold a conversation as good as or arguably even better than humans do, thanks to cutting-edge artificial intelligence systems. Now, frontier AI has become the latest buzzword as concerns grow that... Read More

    October 18, 2023
    by Dan McCue
    FDA Establishes New Advisory Committee on Digital Health Technologies

    WASHINGTON — The Food and Drug Administration is creating a new Digital Health Advisory Committee to help the agency assess... Read More

    WASHINGTON — The Food and Drug Administration is creating a new Digital Health Advisory Committee to help the agency assess and deal with the complex scientific and technical issues related to the burgeoning market of new digital health technologies. These technologies include everything from artificial intelligence... Read More

    Are 3D Mammograms Better Than Standard Imaging? Diverse Study Aims to Find Out

    Are 3D mammograms better than standard 2D imaging for catching advanced cancers? A clinical trial is recruiting thousands of volunteers — including... Read More

    Are 3D mammograms better than standard 2D imaging for catching advanced cancers? A clinical trial is recruiting thousands of volunteers — including a large number of Black women who face disparities in breast cancer death rates — to try to find out. People like Carole Stovall, a psychologist... Read More

    News From The Well
    scroll top